These findings suggest that IL-8 inhibition effectively mitigates acne-like dermatitis, potentially by downregulating CAMP factor expression, highlighting IL-8 and CAMP proteins as promising therapeutic targets in acne treatment. The gene discussed is CXCL8; the disease is dermatitis.